These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 26652389)
1. Interaction of C60 fullerene complexed to doxorubicin with model bilipid membranes and its uptake by HeLa cells. Prylutskyy Y; Bychko A; Sokolova V; Prylutska S; Evstigneev M; Rybalchenko V; Epple M; Scharff P Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():398-403. PubMed ID: 26652389 [TBL] [Abstract][Full Text] [Related]
2. C60 fullerene prevents genotoxic effects of doxorubicin in human lymphocytes in vitro. Afanasieva KS; Prylutska SV; Lozovik AV; Bogutska KI; Sivolob AV; Prylutskyy YI; Ritter U; Scharff P Ukr Biochem J; 2015; 87(1):91-8. PubMed ID: 26036135 [TBL] [Abstract][Full Text] [Related]
3. Fullerene as a transporter for doxorubicin investigated by analytical methods and in vivo imaging. Blazkova I; Viet Nguyen H; Kominkova M; Konecna R; Chudobova D; Krejcova L; Kopel P; Hynek D; Zitka O; Beklova M; Adam V; Kizek R Electrophoresis; 2014 Apr; 35(7):1040-9. PubMed ID: 24254731 [TBL] [Abstract][Full Text] [Related]
5. A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy. Shi J; Liu Y; Wang L; Gao J; Zhang J; Yu X; Ma R; Liu R; Zhang Z Acta Biomater; 2014 Mar; 10(3):1280-91. PubMed ID: 24211343 [TBL] [Abstract][Full Text] [Related]
6. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment. Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158 [TBL] [Abstract][Full Text] [Related]
7. Metallothionein and Superoxide Dismutase-Antioxidative Protein Status in Fullerene-Doxorubicin Delivery to MCF-7 Human Breast Cancer Cells. Kepinska M; Kizek R; Milnerowicz H Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347787 [TBL] [Abstract][Full Text] [Related]
8. Fullerene-conjugated doxorubicin in cells. Liu JH; Cao L; Luo PG; Yang ST; Lu F; Wang H; Meziani MJ; Haque SA; Liu Y; Lacher S; Sun YP ACS Appl Mater Interfaces; 2010 May; 2(5):1384-9. PubMed ID: 20420365 [TBL] [Abstract][Full Text] [Related]
11. Antioxidant action of sugar-pendant C60 fullerenes. Horie M; Fukuhara A; Saito Y; Yoshida Y; Sato H; Ohi H; Obata M; Mikata Y; Yano S; Niki E Bioorg Med Chem Lett; 2009 Oct; 19(20):5902-4. PubMed ID: 19736008 [TBL] [Abstract][Full Text] [Related]
12. Interaction of fullerene nanoparticles with biomembranes: from the partition in lipid membranes to effects on mitochondrial bioenergetics. Santos SM; Dinis AM; Peixoto F; Ferreira L; Jurado AS; Videira RA Toxicol Sci; 2014 Mar; 138(1):117-29. PubMed ID: 24361870 [TBL] [Abstract][Full Text] [Related]
13. Magnetic Fullerene-DNA/Hyaluronic Acid Nanovehicles with Magnetism/Reduction Dual-Responsive Triggered Release. Wang L; Wang Y; Hao J; Dong S Biomacromolecules; 2017 Mar; 18(3):1029-1038. PubMed ID: 28221040 [TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes. Siani P; Donadoni E; Ferraro L; Re F; Di Valentin C Biochim Biophys Acta Biomembr; 2022 Feb; 1864(1):183763. PubMed ID: 34506799 [TBL] [Abstract][Full Text] [Related]
15. Comparative computational study of interaction of C60-fullerene and tris-malonyl-C60-fullerene isomers with lipid bilayer: relation to their antioxidant effect. Bozdaganyan ME; Orekhov PS; Shaytan AK; Shaitan KV PLoS One; 2014; 9(7):e102487. PubMed ID: 25019215 [TBL] [Abstract][Full Text] [Related]
16. Nano-C60 cytotoxicity is due to lipid peroxidation. Sayes CM; Gobin AM; Ausman KD; Mendez J; West JL; Colvin VL Biomaterials; 2005 Dec; 26(36):7587-95. PubMed ID: 16005959 [TBL] [Abstract][Full Text] [Related]
17. Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane. Prylutska S; Bilyy R; Overchuk M; Bychko A; Andreichenko K; Stoika R; Rybalchenko V; Prylutskyy Y; Tsierkezos NG; Ritter U J Biomed Nanotechnol; 2012 Jun; 8(3):522-7. PubMed ID: 22764423 [TBL] [Abstract][Full Text] [Related]
18. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167 [TBL] [Abstract][Full Text] [Related]
19. Biological potential of nanomaterials strongly depends on the suspension media: experimental data on the effects of fullerene C₆₀ on membranes. Drašler B; Drobne D; Poklar Ulrih N; Ota A Protoplasma; 2016 Jan; 253(1):175-84. PubMed ID: 25833389 [TBL] [Abstract][Full Text] [Related]